ReviewDermatologie (Heidelberg, Germany)2026
[Current dermatology guidelines in Germany: selected clinically relevant recommendations].
Review in Dermatologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dermatological guidelines represent an essential foundation for evidence-based diagnosis, treatment, and prevention of skin diseases. In Germany, they are primarily developed under the leadership of the German Dermatological Society (DDG) in collaboration with the Professional Association of German Dermatologists (BVDD), in accordance with the methodological standards of the Association of the Scientific Medical Societies in Germany (AWMF), and are regularly updated. In 2025 and 2026, numerous new or substantially revised guidelines were published, covering a broad spectrum of dermatological diseases. These include both common chronic inflammatory dermatoses and rare diseases, infectious conditions, occupational dermatoses, autoimmune skin disorders, as well as rehabilitative and diagnostic care concepts. The aim of this review is to provide a practice-oriented summary of selected, newly published or updated German guidelines from this period that are of particular clinical relevance to patient care. The selection focused on guidelines addressing substantial innovations in diagnosis or treatment, as well as those addressing common or clinically challenging diseases. As the selected guidelines cover different development levels, they differ in terms of methodology and evidence synthesis. The review therefore focuses on clinically relevant innovations and practical recommendations. Regardless of the respective development level, individual adaptation of each guideline recommendation to the specific patient situation remains essential.
Indexed as
Identifiers
42862287What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.